DropXcell enables founders and pre-seed biotech companies to generate high-quality lead molecules without raising institutional capital upfront. Our platform allows us to rapidly design and affordably quantify 10,000x more antibody candidates, dramatically reducing discovery risk early. We partner with early biotechs through low upfront fees and milestone- and royalty-based economics, aligning incentives and preserving founder ownership.
| Website | https://www.dropxcell.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | High Throughput Screening, Antibody Characterization, Immunology, High Content Screening, Immunological Research, Drug Discovery, Antibody Engineering, Cell Signaling, Biotechnology, Therapeutics, Pharmaceutical Research, Immuno-Oncology, Biotechnology Solutions, Protein Engineering, Drug Development, Biopharmaceutical |
Looking for a particular DropXcell employee's phone or email?
Luke Blauch is the CEO and Founder of DropXcell.
1 people are employed at DropXcell.
DropXcell is based in San Jose, California.